Connect with us

Politics

Donald Trump announces deal to cut weight-loss drug prices to as low as $149 per month

The Trump administration strikes a landmark deal with Eli Lilly and Novo Nordisk to slash costs of obesity drugs and expand Medicare coverage starting in 2026.

Published

on

Donald Trump announces $149 weight-loss drug plan with Eli Lilly and Novo Nordisk | Daily Global Diary
Donald Trump announces a historic deal with Eli Lilly and Novo Nordisk to cut weight-loss drug prices and expand Medicare coverage nationwide.

Donald Trump has announced a sweeping new healthcare initiative that could make weight-loss drugs dramatically more affordable for millions of Americans. The deal, struck between the U.S. government and pharmaceutical giants Eli Lilly and Novo Nordisk, will lower the price of popular obesity and diabetes medications such as Zepbound and Wegovy to as little as $149 per month, starting in 2026.

According to a statement from the White House, the agreement will also expand Medicare coverage to include these drugs — a move that could reshape the $100-billion weight-loss industry.

Donald Trump announces $149 weight-loss drug plan with Eli Lilly and Novo Nordisk | Daily Global Diary

    “The agreement represents a historic reduction in prices for Americans on the two drugs with the highest annual expenditures in the United States,” the statement said.

    The TrumpRx Program

    “Starting in 2026, some pill forms of these medications will cost as low as $149, while injectable versions like Wegovy will drop to around $350 per month,” Trump said.

    Under the new plan:

    • Medicare patients will have co-pays capped at $50.
    • Medicaid users may receive the drugs at little to no cost.
    • Uninsured individuals can access discounts through the new TrumpRx initiative.

    Currently, a month’s supply of these drugs costs between $500 and $650 without insurance — placing them out of reach for many Americans.

    Why this matters

    Obesity remains one of the leading health challenges in the U.S. According to the Centers for Disease Control and Prevention (CDC), over 40% of American adults are classified as obese. Research published in The American Journal of Clinical Nutrition found that medications like Wegovy and Zepbound can help users lose 15–22% of their body weight, or roughly 50 pounds on average.

    However, the high cost of these drugs has been a persistent barrier. Dr. Leslie Golden, an obesity medicine specialist cited by The New York Times, said, “About 75% of my patients can’t afford these medications. Every visit includes a discussion about how much longer we can keep going with this.”

    Studies also show that nearly half of users stop taking the drugs within a year, often due to financial strain — leading to rapid weight regain.

    Medicare expansion and age limits

    Medicare, which primarily covers people aged 65 and older, currently excludes most weight-loss drugs. While previous administrations, including Joe Biden’s, had proposed expanding access, those efforts stalled.

    Under the Trump plan, coverage will extend to patients with severe obesity or weight-related health conditions, such as Type 2 diabetes or heart disease. Eligible recipients will pay a $50 copayment, while others can qualify for partial subsidies.

    Health and Human Services Secretary Robert F. Kennedy Jr. called obesity a “disease of poverty,” emphasizing that lower-income Americans rarely have access to effective weight-management treatments.

    Donald Trump announces $149 weight-loss drug plan with Eli Lilly and Novo Nordisk | Daily Global Diary

    “This program ensures that lifesaving medications are not just for the wealthy,” Kennedy said. “It levels the playing field in preventive healthcare.”

    A shift in pharmaceutical economics

    The deal marks a significant policy victory for the Trump administration as it seeks to curb drug prices across categories. Analysts note that it could also pressure other pharmaceutical companies to lower the cost of blockbuster treatments, especially in the fast-growing GLP-1 drug class used for diabetes and weight management.

    With more than 40 million Americans projected to qualify for obesity medications under expanded Medicare rules, this initiative could redefine how the U.S. tackles one of its most expensive and widespread health crises.

    Politics

    “Egg on Their Face”: DOJ’s Failed Trump Revenge Prosecutions Trigger Legal Embarrassment

    From dismissed indictments to grand jury rejections, the Justice Department’s attempts to prosecute Trump critics have unraveled in dramatic fashion

    Published

    on

    By

    “Egg on Their Face”: DOJ’s Failed Trump Revenge Prosecutions Trigger Legal Embarrassment
    The U.S. Department of Justice faces mounting criticism after repeated legal failures in high-profile Trump-linked prosecutions

    The U.S. Department of Justice (DOJ) is facing growing scrutiny and embarrassment after a string of high-profile failures tied to attempts to prosecute critics of President Donald Trump. What was meant to project strength and accountability has instead exposed deep cracks in federal prosecution strategy, according to legal experts and former prosecutors.

    In a sequence of setbacks rarely seen in modern federal law enforcement, the DOJ has suffered dismissed indictments, blocked evidence, and, most strikingly, two federal grand juries refusing to indict one of its key targets — New York Attorney General Letitia James.

    The most damaging blow came on December 11, when a second grand jury declined to issue charges against James, just days after another grand jury rejected the same effort. Her attorney, Abbe Lowell, called the outcome “unprecedented,” a sentiment echoed by multiple former federal prosecutors.

    “Egg on Their Face”: DOJ’s Failed Trump Revenge Prosecutions Trigger Legal Embarrassment


    Earlier indictments against both James and former FBI Director James Comey were thrown out after a federal judge ruled that the special prosecutor who brought the cases, Lindsey Halligan, had been unlawfully appointed. Adding to the DOJ’s woes, a judge also blocked prosecutors from using key evidence against Comey, citing possible constitutional violations.

    “This is an embarrassment,” said Neama Rahmani, a former federal prosecutor. “The last thing you want to be as a prosecutor is to be on the defensive — and that’s exactly what’s happening here.”

    Trump’s Longstanding Vendettas

    Trump’s hostility toward both Comey and James dates back years. He fired Comey in 2017 while the FBI was investigating potential links between Trump’s 2016 campaign and Russia. James later sued Trump in 2022 for civil fraud related to his real estate business, a case that deeply angered the former president.

    In a September 20 social media post, Trump openly called for the prosecution of Comey, James, and Sen. Adam Schiff of California. While investigations were launched, results have been deeply underwhelming.

    An NBC News report revealed that the DOJ’s investigation into Schiff has stalled entirely, with internal probes reportedly underway to examine how the case was mishandled. The DOJ has declined to comment on its performance in these matters.

    Loyalty Over Experience

    According to multiple reports, career prosecutors — including the interim U.S. attorney for the Eastern District of Virginia — had previously concluded the evidence against James and Comey was too weak to sustain charges. Trump publicly criticized and fired the U.S. attorney, later urging Attorney General Pam Bondi to appoint Lindsey Halligan, his former personal lawyer, despite her lack of prosecutorial experience.

    Bondi acted swiftly, and Halligan secured indictments against both Comey and James. But the cases quickly collapsed.

    In Comey’s case, Magistrate Judge William Fitzpatrick described a “disturbing pattern of profound investigative missteps,” including possible violations of the Fourth Amendment. Judge Cameron McGowan Currie, a Clinton appointee, ultimately dismissed all charges after ruling Halligan’s appointment unlawful.

    “The prosecutions haven’t amounted to much in court,” said Carl Tobias, a law professor at the University of Richmond. “Except to harass them — which may have been the point.”

    Grand Jury Rejections: A Rare Humiliation

    Perhaps the most humiliating moment for the DOJ came when two separate grand juries rejected efforts to re-indict Letitia James. Legal experts stress how extraordinary this is.

    Former federal prosecutor Mitchell Epner said he sought hundreds of indictments in his career and failed only once. “To go before two grand juries in a week and fail both times is humiliating and a repudiation of the prosecution,” he said.

    Barbara McQuade, former U.S. attorney under President Barack Obama, was even more blunt:
    “When prosecutors are selected based on loyalty rather than experience and integrity, this is the sort of garbage we can expect.”

    “Egg on Their Face”: DOJ’s Failed Trump Revenge Prosecutions Trigger Legal Embarrassment


    Comey Case Still on Shaky Ground

    The DOJ has suggested it may try to re-indict Comey, but significant hurdles remain. A federal judge has temporarily blocked prosecutors from using key evidence obtained during a separate 2017 investigation, ruling it may have been seized unconstitutionally.

    Even if that hurdle is cleared, prosecutors face another problem: time. The original indictment was issued just days before the statute of limitations expired. Comey’s defense team argues that because the indictment was void, the government cannot rely on the usual six-month extension for refiling charges.

    “The DOJ — and Halligan in particular — have egg on their face,” Rahmani said. “These are massive failures by the Justice Department.”

    A Pattern of Collapse

    What emerges from this saga is not just a legal defeat, but a broader institutional reckoning. From judicial rebukes to grand jury resistance, the DOJ’s efforts against Trump’s perceived enemies have collapsed under scrutiny.

    Instead of delivering accountability, the prosecutions have raised uncomfortable questions about politicization, competence, and abuse of power — questions that now hang heavily over the Justice Department itself.

    Continue Reading

    Politics

    Bill Maher Sparks Fiery Clash With Ana Kasparian on Israel as Question About ‘That Dress’ Escalates Debate

    “Where would you live in the Middle East… in that dress?” Bill Maher’s question turns tense as Ana Kasparian pushes back on his assumptions.

    Published

    on

    By

    Bill Maher and Ana Kasparian’s Heated Israel Debate Goes Viral on Club Random
    Bill Maher and Ana Kasparian during their heated debate on Club Random, where a question about the Middle East suddenly turned personal.

    A casual, free-flowing podcast conversation quickly morphed into a heated geopolitical debate when comedian and commentator Bill Maher clashed with Ana Kasparian of The Young Turks during her recent appearance on his show, Club Random.

    What began as a typical Maher-style discussion — part politics, part humor, part provocation — took a sharper turn when the topic shifted to the Middle East and whether a Western woman would feel comfortable living there.

    Maher, who often stresses that he is not formally aligned with any political organization, posed a hypothetical question to Kasparian:

    “Ana, you’ve got to go live in the Middle East… where would you live?”

    He began listing countries one by one — Pakistan, Egypt, Jordan, Lebanon, Syria — adding commentary that blended sarcasm with dark humor. Kasparian immediately challenged his characterization of Syria, pointing out that parts of the country are still controlled by extremist groups.

    ALSO READ : Kylie Jenner and Timothée Chalamet Steal the Spotlight in Matching Orange Looks at Marty Supreme Premiere

    But Maher barreled on, even referencing Yemen “under Houthi rule,” before pivoting to Israel.

    Tel Aviv or the West Bank — Ramallah is wonderful in the fall, it gets lovely,” Maher said. What followed, however, pushed the discussion into far more personal territory.

    Looking directly at Kasparian’s outfit, Maher asked:
    “What city would you live in? What do you think you’d be comfortable in that dress?”

    The remark noticeably shifted the tone of the conversation. Kasparian, known for her direct style on The Young Turks, pushed back firmly, suggesting Maher was oversimplifying deeply complex cultures and ignoring regional differences in laws, norms and women’s rights.

    Maher defended his approach, insisting he was speaking about general realities in the region, not making personal judgments. But by this point, the exchange had clearly escalated beyond a casual hypothetical.

    MV5BMjAwZGE1Y2QtNjg1OC00YjdiLWI5NDctYjkwMDA1ODk0Y2M5XkEyXkFqcGc@. V1 Daily Global Diary - Authentic Global News


    A Debate That Mirrors a Larger Global Divide

    The tense moment reflected a broader, ongoing debate playing out across social media and political circles: How does the West talk about the Middle East without flattening its complexity?

    Kasparian argued that sweeping generalizations — especially about women’s freedoms — feed into stereotypes that oversimplify lived experiences. Maher countered that refusing to acknowledge differences in legal and cultural realities is equally misleading.

    As clips of the exchange circulated online, reactions were predictably polarized. Supporters of Maher praised him for “saying the uncomfortable truth,” while fans of Kasparian applauded her for challenging what they viewed as reductive framing.

    Why This Exchange Matters

    Both Maher and Kasparian command large online audiences. Maher hosts the long-running HBO show Real Time with Bill Maher, while Kasparian reaches millions through TYT’s digital platforms. Their confrontation — part humor, part philosophy, part geopolitics — reflects how discussions about Israel, women’s rights, and Middle Eastern politics have become flashpoints in Western media.

    It also highlights something deeper: When conversations about geopolitics intersect with identity and personal appearance, the tension is almost inevitable.

    And on Club Random, tension is something Maher rarely shies away from.

    Continue Reading

    Politics

    “If I Can’t Beat Jimmy Kimmel, I Shouldn’t Be President…” Trump Drops Bold Claim Ahead of Hosting Kennedy Center Honors

    At a pre-event gathering, President Donald Trump predicted record-breaking ratings — and took a sharp swipe at late-night host Jimmy Kimmel.

    Published

    on

    By

    Trump Says “If I Can’t Beat Jimmy Kimmel, I Shouldn’t Be President” Ahead of Kennedy Center Honors
    President Donald Trump speaks ahead of hosting the Kennedy Center Honors, predicting record ratings and taking aim at Jimmy Kimmel.

    On the eve of hosting the prestigious Kennedy Center Honors, Donald Trump did what he often does best — make headlines before the event even begins. Speaking confidently at a pre-show gathering, Trump made several bold predictions about the upcoming ceremony, including one that instantly went viral.

    “I believe this will be the highest-rated show they’ve ever done,” he told attendees, referring to the televised broadcast that will air later this month on CBS and Paramount+. With characteristic bravado, Trump added that while the awards have seen strong viewership in the past, “there’s nothing like what’s gonna happen tomorrow night.”

    But it wasn’t his ratings prediction that raised eyebrows — it was his jab at late-night host Jimmy Kimmel.

    “I’ve watched some of the people that host,” Trump said with a smirk. “Jimmy Kimmel was horrible. And if I can’t beat out Jimmy Kimmel in terms of talent, then I don’t think I should be president.

    ALSO READ : “Treylon Burks Stuns NFL With Gravity-Defying One-Handed TD… Fans Say ‘This Is His Odell Moment’”

    Those in the room reacted with a mixture of laughter and surprise. Trump, who has a long-running feud with several late-night comedians, seemed to relish the moment. Though Kimmel has never actually hosted the Kennedy Center Honors, he did appear in the 2012 ceremony during a tribute to David Letterman — a detail Trump apparently glossed over.

    Kimmel, meanwhile, has hosted the Academy Awards, the Primetime Emmys, and fronts his long-running late-night show Jimmy Kimmel Live! Yet Trump’s comment implied he expected comparisons to be inevitable — and not necessarily favorable from the mainstream press.

    Trump Says “If I Can’t Beat Jimmy Kimmel, I Shouldn’t Be President” Ahead of Kennedy Center Honors


    “We never had a president hosting the awards before,” Trump reminded the audience. “This is a first. I’m sure they’ll give me great reviews, right? They’ll say, ‘He was horrible. He was terrible.’ No, we’ll do fine.”

    His tone shifted briefly toward sincerity as he thanked the attendees and spoke about the emotional weight of the upcoming evening.
    “This is a special night,” he said. “By the end of these two days, you’re gonna say this is one of the most special days in your life.”

    But even in the sentimentality, Trump couldn’t resist one more prediction — that several guests had already told him the day felt life-changing.

    With Trump’s boldness, the anticipation around the Honors ceremony is higher than ever — not only for the performances, but to see just how the president’s first hosting attempt will unfold on stage. One thing is certain: the broadcast won’t lack drama, humor, or spectacle.

    Continue Reading
    Advertisement

    Trending